New York Times

New York Times
Share

New York Times

 •  August 29

Samantha Peters is trading in her foundation and concealer for an IV. For years, she’s had a daily makeup routine to cover dark blotches on her face and the discoloration and scarring on her arms that won’t go away — a common problem for those with darker skin tones. Now she’s hoping a new treatment, intravenous glutathione, will accomplish what...

New York Times

 •  August 8, 2015

WASHINGTON — The Obama administration has decided that Medicare will pay for one of the newest, most expensive cancer medications, which costs about $178,000 for a standard course of treatment.
Patients, doctors, hospital executives and insurers have expressed concern about the high cost of prescription drugs, especially new cancer medicines and ...

New York Times

 •  April 24, 2015

Israel Sapoznick doesn’t do well in hospitals.
At 89, he sees poorly, uses a wheelchair, and suffers from mild to moderate dementia. Even the ambulette ride from the Hebrew Home at Riverdale, where he lives in the memory care unit, can prove stressful.
“It is very scary for an older person to be in a hospital, and it’s hard for the family, too,” ...

New York Times

 •  January 2, 2015

Medical experts seeking to stem the Ebola epidemic are sharply divided over whether most patients in West Africa should, or can, be given intravenous hydration, a therapy that is standard in developed countries. Some argue that more aggressive treatment with IV fluids is medically possible and a moral obligation. But others counsel caution, saying ...